- Home
- BTDR vs PTGX Comparison
BTDR vs PTGX Comparison
Compare BTDR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTDR
- PTGX
- Stock Information
- Founded
- BTDR 2021
- PTGX 2006
- Country
- BTDR Singapore
- PTGX United States
- Employees
- BTDR N/A
- PTGX N/A
- Industry
- BTDR EDP Services
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- BTDR Technology
- PTGX Health Care
- Exchange
- BTDR Nasdaq
- PTGX Nasdaq
- Market Cap
- BTDR 3.8B
- PTGX 4.0B
- IPO Year
- BTDR N/A
- PTGX 2016
- Fundamental
- Price
- BTDR $25.55
- PTGX $76.98
- Analyst Decision
- BTDR Strong Buy
- PTGX Strong Buy
- Analyst Count
- BTDR 10
- PTGX 8
- Target Price
- BTDR $26.70
- PTGX $74.13
- AVG Volume (30 Days)
- BTDR 9.1M
- PTGX 1.6M
- Earning Date
- BTDR 11-17-2025
- PTGX 11-06-2025
- Dividend Yield
- BTDR N/A
- PTGX N/A
- EPS Growth
- BTDR N/A
- PTGX N/A
- EPS
- BTDR N/A
- PTGX 0.80
- Revenue
- BTDR $356,757,000.00
- PTGX $209,180,000.00
- Revenue This Year
- BTDR $64.30
- PTGX N/A
- Revenue Next Year
- BTDR $93.32
- PTGX $243.08
- P/E Ratio
- BTDR N/A
- PTGX $96.33
- Revenue Growth
- BTDR N/A
- PTGX N/A
- 52 Week Low
- BTDR $6.84
- PTGX $33.31
- 52 Week High
- BTDR $27.80
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- BTDR 67.97
- PTGX 62.09
- Support Level
- BTDR $22.90
- PTGX $74.62
- Resistance Level
- BTDR $27.80
- PTGX $93.25
- Average True Range (ATR)
- BTDR 2.31
- PTGX 4.77
- MACD
- BTDR 0.54
- PTGX 0.59
- Stochastic Oscillator
- BTDR 78.77
- PTGX 47.53
About BTDR Bitdeer Technologies Group
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.